Perspective Therapeutics Price Chart
Perspective Therapeutics Volume Chart
Perspective Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
-0.02(-0.51%)
| Open | $3.95 |
|---|---|
| Close | $3.93 |
| Low | $3.85 |
| Low Change | -0.10 (-2.53%) |
| High | $4.00 |
| High Change | +0.05 (+1.25%) |
| Range | $0.15 |
| Volume | 44.617K |
| Dollar Volume | $175.34K |
Regular Trading Hours Yesterday
-0.30(-7.06%)
| Open | $4.25 |
|---|---|
| Close | $3.95 |
| Low | $3.94 |
| Low Change | -0.31 (-7.29%) |
| High | $4.31 |
| High Change | +0.06 (+1.41%) |
| Range | $0.37 |
| Volume | 1.282M |
| Dollar Volume | $5.06M |
Premarket Yesterday
-0.04(-0.92%)
| Open | $4.34 |
|---|---|
| Close | $4.30 |
| Low | $4.30 |
| Low Change | -0.04 (-0.92%) |
| High | $4.37 |
| High Change | +0.03 (+0.69%) |
| Range | $0.07 |
| Volume | 1.124K |
| Dollar Volume | $4.83K |
Perspective Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $4.40 |
|---|---|
| 10 Day Moving Average (SMA10) | $4.41 |
| 20 Day Moving Average (SMA20) | $4.39 |
| 50 Day Moving Average (SMA50) | $4.74 |
| 100 Day Moving Average (SMA100) | $3.94 |
| 200 Day Moving Average (SMA200) | $3.64 |
Perspective Therapeutics Statistics
| Average Volume (30 Days) | 1.45M |
|---|---|
| P/E Ratio (Current) | -4.74 |
| EPS (Current) | -$0.90 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$95.37M |
| Cash Ratio | 1.07 |
| Current Ratio | 5.17 |
| Quick Ratio | 5.17 |
| Debt to Equity | 0.01 |
| Enterprise Value | $457.85M |
| EV to EBITDA | -4.15 |
| EV to Sales | 517.93 |
| Price to Book | 2.35 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 550.74 |
| Return on Assets | -0.39% |
| Return on Equity | -0.50% |
Perspective Therapeutics Stock Splits
There has been 1 stock split for Perspective Therapeutics (CATX). The reverse stock split occured on June 17, 2024 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 17, 2024 | Reverse | 10:1 |
Perspective Therapeutics Dividends
There have been no dividends for Perspective Therapeutics (CATX).